Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
76.29
+2.17 (2.93%)
At close: Apr 17, 2026, 4:00 PM EDT
76.10
-0.19 (-0.25%)
After-hours: Apr 17, 2026, 7:00 PM EDT

Veradermics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.000.0000.06
Debt / EBITDA Ratio
00--0.04
Debt / FCF Ratio
00--0.06
Net Debt / Equity Ratio
1.171.171.100.70
Net Debt / EBITDA Ratio
1.961.961.980.90
Net Debt / FCF Ratio
1.981.982.241.15
Quick Ratio
15.5015.5011.255.34
Current Ratio
16.6616.6611.775.75
Return on Equity (ROE)
-72.06%-72.06%-82.08%-120.15%
Return on Assets (ROA)
-69.51%-69.51%-73.27%-98.64%
Return on Invested Capital (ROIC)
23527.50%23527.50%1321.39%969.99%
Return on Capital Employed (ROCE)
-74.48%-74.48%-81.98%-119.39%
Buyback Yield / Dilution
--1.09%0.00%-
Total Shareholder Return
--1.09%0.00%-
Updated Jan 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q